SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15324523
Source:
http://linkedlifedata.com/resource/pubmed/id/15324523
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004096
,
umls-concept:C0034380
,
umls-concept:C0231441
,
umls-concept:C0443218
,
umls-concept:C1276807
,
umls-concept:C1280500
,
umls-concept:C1707455
,
umls-concept:C2587213
,
umls-concept:C2827483
pubmed:issue
8
pubmed:dateCreated
2004-8-24
pubmed:abstractText
Budesonide/formoterol in a single inhaler is an effective therapy for asthma. We investigated whether adjustable maintenance dosing with budesonide/formoterol could maintain health-related quality of life (HRQL) and asthma control.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0351014
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Asthmatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Budesonide
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations
,
http://linkedlifedata.com/resource/pubmed/chemical/Ethanolamines
,
http://linkedlifedata.com/resource/pubmed/chemical/formoterol
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0300-7995
pubmed:author
pubmed-author:BACHR ORO
,
pubmed-author:BrüggenjürgenBB
,
pubmed-author:KardosPP
,
pubmed-author:Meyer-SabellekWW
,
pubmed-author:RichterKK
,
pubmed-author:VogelmeierCC
,
pubmed-author:WillichS NSN
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1209-20
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15324523-Administration, Inhalation
,
pubmed-meshheading:15324523-Adolescent
,
pubmed-meshheading:15324523-Adult
,
pubmed-meshheading:15324523-Aged
,
pubmed-meshheading:15324523-Anti-Asthmatic Agents
,
pubmed-meshheading:15324523-Asthma
,
pubmed-meshheading:15324523-Budesonide
,
pubmed-meshheading:15324523-Drug Administration Schedule
,
pubmed-meshheading:15324523-Drug Combinations
,
pubmed-meshheading:15324523-Ethanolamines
,
pubmed-meshheading:15324523-Female
,
pubmed-meshheading:15324523-Humans
,
pubmed-meshheading:15324523-Male
,
pubmed-meshheading:15324523-Metered Dose Inhalers
,
pubmed-meshheading:15324523-Middle Aged
,
pubmed-meshheading:15324523-Quality of Life
,
pubmed-meshheading:15324523-Respiratory Function Tests
,
pubmed-meshheading:15324523-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing.
pubmed:affiliation
Mainz University Hospital, Germany. R.Buhl@3-med.klinik.uni-mainz.de
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study